David J. Hunt

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 03, 2026

Biallelic pathogenic variants in EXOSC3 mediate renal thrombotic microangiopathy of the kidney.

Biallelic pathogenic variants in EXOSC3 mediate renal thrombotic microangiopathy of the kidney.

Journal: Kidney international

Published: February 10, 2026

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort.

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: January 09, 2026

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort.

A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient Cohort.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: January 09, 2026

The potential for dementia prevention through vaccination.

The potential for dementia prevention through vaccination.

Journal: The Lancet. Neurology

Published: December 21, 2025

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 05, 2025

Whole-genome sequencing uncovers diverse genetic causes and phenotypic signatures in infantile nystagmus and albinism.

Whole-genome sequencing uncovers diverse genetic causes and phenotypic signatures in infantile nystagmus and albinism.

Journal: NPJ genomic medicine

Published: September 30, 2025

An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.

An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.

Journal: American journal of human genetics

Published: August 08, 2025

Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study.

Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study.

Journal: The Lancet. Rheumatology

Published: July 31, 2025

Publisher Correction: Analysis of R-loop forming regions identifies RNU2-2 and RNU5B-1 as neurodevelopmental disorder genes.

Publisher Correction: Analysis of R-loop forming regions identifies RNU2-2 and RNU5B-1 as neurodevelopmental disorder genes.

Journal: Nature genetics

Published: June 24, 2025

Blood-based biomarker discovery in motor neuron disease using nucleic acid-linked immuno-sandwich assay.

Blood-based biomarker discovery in motor neuron disease using nucleic acid-linked immuno-sandwich assay.

Journal: Brain communications

Published: May 02, 2025

Risk of cardiovascular and autoimmune disease in people with multiple sclerosis on long-term interferon-β therapy.

Risk of cardiovascular and autoimmune disease in people with multiple sclerosis on long-term interferon-β therapy.

Journal: Brain communications

Published: March 31, 2025

Showing 1-12 of 109

Last Updated: 09/26/2026